management

Learn of Updates in the Management of Prediabetes and Type II Diabetes

by

OSUWexnerbloglogo2014 Learn of Updates in the Management of Prediabetes and and Type II Diabetes. Learn of Updates in the Management of Prediabetes and and Type II Diabetes. The International Diabetes Federation estimates there are 537 million individuals with diabetes worldwide. And that’s not even counting the patients that go undiagnosed. In the US, we estimate that 1/3 of eligible patients are not screened. Even with screening, there’s a gigantic gap in prediabetes diagnosis and treatment. Those in Primary care are really at the forefront of diabetes & prediabetes care. With 11% of the adult population affected by Diabetes, every healthcare worker must become comfortable with the care and treatment of these patients. So today to help Dr. Mao discuss the updates in the prevention and treatment of diabetes, we’ve invited her colleague Jennifer Sabatino who is a Doctor of Pharmacy and practicing Clinical Pharmacist at Ohio State University. They will cover the basics and updates over the past half a decade or so including both non-pharmacologic and pharmacologic treatment options.

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to:

  • Understand the epidemiology and definition of Prediabetes and Type II diabetes (T2DM).
  • Be familiar with the different treatment options for Prediabetes to prevent progression to T2DM.
  • Understand the pharmacologic and non-pharmacologic treatments for T2DM.
  • Recognize the place in therapy of Glucagon-Like Peptide Receptor Agonists (GLP-1 RA) and Sodium-Glucose Cotransporter 2 Inhibitors (SGLT2i) for T2DM.
  • Explore a new class of medications for diabetes treatment, the Glucose-Dependent Insulinotropic Polypeptide (GIP)/Glucagon-Like Peptide Receptor Agonist (GLP-1 RA).

You’ll also learn about the following:

  • Supplements
  • Prediabetes treatment Outcomes
  • Pregnancy and lactation

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

Learn About Psychiatric and Behavioral Health Management in Chronic Health Conditions

by

OSUWexnerbloglogo2014 Learn About Psychiatric and Behavioral Health Management in Chronic Health Conditions. Chronic illnesses are linked with much higher rates of depression and mental illness. But that’s not the only issue. The problem is really bidirectional. Depressed patients with chronic illness, have worse health outcomes. Diabetic patients with depression for example, have lower glycemic control, decreased activity levels, higher weight and higher levels of complication and functional impairment.So today, to discuss the effects of Psychiatric and Behavioral Health Management in Chronic Health Conditions are two of Ohio State University’s Psychiatry experts. Dr. Kevin Johns is an Assistant Professor of Psychiatry who specializes in treating patients with chronic medical problems. He also works to create collaborate care models to help non-psychiatric providers such as myself better address their patient’s mental health needs. Dr. Ashleigh Pona has a PhD in clinical psychology and specializes in bariatric psychology and & eating disorders.

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to:

  • Understand why depression management is an important part of managing general medical conditions.
  • Learn how to diagnose and treat depression in patients with other medical conditions.
  • Teach learners different therapeutic strategies that can be used to manage behavioral health concerns
  • Teach learners why it is important to consider the biopsychosocial model of health in assessing and treating chronic disease

You’ll also learn about the following:

  • Chronic Illness & Depression
  • Telecounseling
  • Mindfulness Apps
  • Mental Health Screening

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

Learn About Surgical Management of Constipation, Fecal Incontinence, and Rectal Prolapse

by

OSUWexnerbloglogo2014 Learn About Surgical Management of Constipation, Fecal Incontinence, and Rectal Prolapse. Decades after Lane’s death, surgeons have now developed renewed interest in colectomy as treatment for constipation. The patient selection is of course much more rigorous. On this CME webcast to discuss surgical treatment of constipation as well as other pelvic floor abnormalities such as fecal incontinence and rectal prolapse is one of Ohio State University’s Colorectal experts. We’re pleased to introduce Associate Professor of Surgery Dr Amber Traugott.

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to:

  • Describe the surgical evaluation of patients referred for constipation, fecal incontinence, or rectal prolapse.
  • Describe common surgical treatment options for constipation, fecal incontinence, and rectal prolapse.

You’ll also learn about the following:

  • Pelvic Floor Dysfunction
  • Frequency of Surgical Treatment
  • Special Testing
  • Anorectal Exams
  • Constipation Care

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

Physicians Learn About Lipid Management on Webcast

by

OSUWexnerbloglogo2014 Physicians Learn About Lipid Management on Webcast. High levels of cholesterol, specifically low-density lipoprotein can lead to atherosclerosis, heart attacks and strokes. So how do we balance and manage the body’s needs for these essential building blocks with the risks of deadly disease? Fortunately, the American College of Cardiology and the American Heart Association have guidelines to address Cholesterol management. Here to discuss the intricacies of those guidelines are two of Ohio State University’s experts of Cardiovascular Medicine. I’m happy to welcome to MedNet Associate Professor of Cardiology Dr John Larry and Doctor of Pharmacology and Clinical Pharmacist Amy James.

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to do the following:
Understand guidelines and approach for management of dyslipidemias
Review treatment options beyond statins
Share clinical pearls of hyperlipidemia management

You’ll also learn about the following:

  • Terminology
  • Prevalence
  • Lipid profile monitoring
  • Pregnancy & Lactation
  • Referral

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

Experts Discuss Inpatient Management of Diabetes on CME Webcast

by

OSUWexnerbloglogo2014 Experts Discuss Inpatient Management of Diabetes on CME Webcast. In the 100 years since the discovery of insulin by Banting and Best, insulin remains the cornerstone of treatment for diabetes but we now have better formulations of insulin as well as new oral diabetes medications that are improving the lives of diabetics like never before. But when patients with diabetes are admitted to the hospital with medical or surgical conditions, the management of diabetes can become complicated. On this CME webcast, we are going to show you the management strategies that you can use for your inpatients with diabetes to ensure the best outcomes. Let me welcome my guests. Dr. Kathleen Dungan is an endocrinologist and Professor of Internal Medicine from the Ohio State University. And Dr. Roger Harty is an Assistant Professor of Internal Medicine, also from the Division of Endocrinology.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: describe the scope of hyperglycemia in the hospital and rationale for glucose control; illustrate management strategies based upon illness severity and other clinical characteristics; describe methods for determining inpatient insulin dosing; and provide an overview of discharge considerations for patients with diabetes in the inpatient setting.

You’ll also learn about the following:

  • Critical illness and diabetes control
  • Risks of hypoglycemia

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.